Piratvisuth, T., Komolmit, P., Tanwandee, T., Sukeepaisarnjaroen, W., Chan, H., Pessôa, M. G., . . . Trylesinski, A. (2019). 52-Week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-Positive Chronic Hepatitis B.
Citação norma ChicagoPiratvisuth, Teerha, et al. 52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B. 2019.
Citação norma MLAPiratvisuth, Teerha, et al. 52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B. 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.